Cofounder And Ceo
CurrentMedostic is a early stage medical company that develops closed-loop pharmaceutical and digital therapeutic systems to individually monitor and treat metabolic and nutritional needs of critical care patients.Clinical Decision Support Software / Digital Therapeutics:Medostic develops proprietary integrated inpatient clinical decision support software to personalize metabolic treatment of critical care patients with the mission of improving glycemic control, inflammation, nutrition and other indications for use common during the acute phase of illness and injury.Biosensor Metabolomic Monitoring:Medostic combines measurements of glucose, lactate and other metabolites of the Body Energy State with proprietary algorithms to prescribe personalized infusion administration of formulations and therapeutics for critical care patients. Formulations and Therapeutics:Medostic proprietary formulations and therapeutics will be indicated for use for metabolic and nutritional needs including glycemic control and other indications for use of critical care patients and are currently in clinical trials.We are pleased to announce that Medostic has been selected as a Spring 2019 team at Berkeley SkyDeck. As a top global startup accelerator, SkyDeck helps companies by connecting them to exceptional talent, world-class resources, the powerful startup ecosystem of Silicon Valley, and the renowned faculty and alumni network of UC Berkeley. Please follow us for more updates from Medostic and Berkeley SkyDeck!
